TY - JOUR
T1 - Inherited hemoglobin disorders in Guinea-Bissau, West Africa
T2 - a population study
AU - Masmas, Tania N
AU - Garly, May-Lill
AU - Lisse, Ida M
AU - Rodriques, Amabelia
AU - Petersen, Pia T
AU - Birgens, Henrik
PY - 2006
Y1 - 2006
N2 - The determination of the prevalence of inherited hemoglobin (Hb) disorders in endemic areas is important in order to develop programs for their control and management. The aim of this study is to determine the prevalence of inherited Hb diseases in Guinea-Bissau which is situated on the west coast of Africa, between Senegal and Guinea. One thousand and fifty-seven blood samples were collected and analyzed with high performance liquid chromatography (HPLC) for detection of beta-thalassemia (thal) and Hb variants, and by gap polymerase chain reaction (gap-PCR) for the detection of deletions in the alpha-globin genes. We found 4.7% children were heterozygous for Hb S [beta6(A3)Glu-->Val, GAG -->GTG], 0.2% were homozygous for Hb S, and 0.3% were heterozygous for Hb C [beta6(A3)Glu-->Lys, GAG -->AAG]. One child had heterozygous beta+-thal, 13.8% were heterozygous for the -alpha3.7 deletion, 1.5% were homozygous for the -alpha3.7 deletion, and 1.5% were heterozygous for the -alpha4.2 deletion. We recommend national screening programs to focus primarily on sickle cell disease, since beta-thal is rare, and the observed alpha-thal deletions are of minor genetic importance.
AB - The determination of the prevalence of inherited hemoglobin (Hb) disorders in endemic areas is important in order to develop programs for their control and management. The aim of this study is to determine the prevalence of inherited Hb diseases in Guinea-Bissau which is situated on the west coast of Africa, between Senegal and Guinea. One thousand and fifty-seven blood samples were collected and analyzed with high performance liquid chromatography (HPLC) for detection of beta-thalassemia (thal) and Hb variants, and by gap polymerase chain reaction (gap-PCR) for the detection of deletions in the alpha-globin genes. We found 4.7% children were heterozygous for Hb S [beta6(A3)Glu-->Val, GAG -->GTG], 0.2% were homozygous for Hb S, and 0.3% were heterozygous for Hb C [beta6(A3)Glu-->Lys, GAG -->AAG]. One child had heterozygous beta+-thal, 13.8% were heterozygous for the -alpha3.7 deletion, 1.5% were homozygous for the -alpha3.7 deletion, and 1.5% were heterozygous for the -alpha4.2 deletion. We recommend national screening programs to focus primarily on sickle cell disease, since beta-thal is rare, and the observed alpha-thal deletions are of minor genetic importance.
KW - Anemia, Sickle Cell/epidemiology
KW - Chromatography, High Pressure Liquid
KW - Cross-Sectional Studies
KW - Developing Countries
KW - Female
KW - Genetic Carrier Screening/methods
KW - Globins/genetics
KW - Guinea-Bissau/epidemiology
KW - Hemoglobin C/analysis
KW - Hemoglobin, Sickle/analysis
KW - Humans
KW - Infant
KW - Male
KW - Mass Screening/methods
KW - Point Mutation/genetics
KW - Sequence Analysis, DNA/methods
KW - beta-Thalassemia/epidemiology
U2 - 10.1080/03630260600755385
DO - 10.1080/03630260600755385
M3 - Journal article
C2 - 16840226
SN - 0363-0269
VL - 30
SP - 355
EP - 364
JO - Hemoglobin
JF - Hemoglobin
IS - 3
ER -